Filing Details
- Accession Number:
- 0001127602-15-004370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-04 17:53:05
- Reporting Period:
- 2015-02-03
- Filing Date:
- 2015-02-04
- Accepted Time:
- 2015-02-04 17:53:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235598 | M James Frates | Connaught House 1 Burlington Road Dublin 4 Ireland | Svp & Cfo, Alkermes Plc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-02-03 | 10,000 | $9.21 | 87,162 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-02-03 | 6,800 | $70.39 | 80,362 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-02-03 | 2,200 | $71.43 | 78,162 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-02-03 | 1,000 | $72.49 | 77,162 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2015-02-03 | 10,000 | $0.00 | 10,000 | $9.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2019-11-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 4,000 | Indirect | By Sons |
| Ordinary Shares | 57,000 | Indirect | By GRAT |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.01 to $71.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.07 to $72.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held by James M. Frates Grantor Retained Annuity Trust dated March 14, 2014 (the "GRAT"). The Reporting Person is a trustee and beneficiary of the GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the GRAT.
- These options are fully vested in accordance with their terms.
Billionaire Hedge Funds
